# Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

> **NCT00309309** · PHASE2 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 10 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Rosiglitazone

## Key facts

- **NCT ID:** NCT00309309
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2007-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309309, "Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00309309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*